Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Med Sci Law ; 61(2): 122-129, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33236683

RESUMEN

Etizolam is a thienodiazepine that although licensed for clinical usage in Japan, India and South Korea is commonly abused and detected in post-mortem cases around the world. To date, there are limited data in the literature to allow for the interpretation of blood concentrations of etizolam in post-mortem cases. A liquid chromatography with tandem mass spectrometry method was used to quantitate etizolam concentrations in 28 post-mortem cases where etizolam was detected. The median concentration of etizolam in femoral blood was 8.5 ng/mL (range 1.0-172.0 ng/mL; n = 24); in antemortem plasma, the etizolam concentration range was 4-44 ng/mL (n = 4). The mean age of the individuals abusing etizolam was 38.5 ± 8.4 years (median 39 years), with the majority being male (86%). In all of the cases, multiple drugs were detected, with the most common being pregabalin (61%) followed by morphine/heroin (54%), diazepam (54%) and benzoylecgonine (21%), illustrating the increasing problem of poly-substance use in drug abusers. The cause of death in the cases in which etizolam was detected was multi-drug toxicity in 87.5% of the cases, with 12.5% unrelated to drug use (hangings and blunt-force trauma). These data will further help forensic practitioners with the interpretation of post-mortem etizolam concentrations.


Asunto(s)
Análisis Químico de la Sangre , Diazepam/análogos & derivados , Toxicología Forense , Detección de Abuso de Sustancias/métodos , Adulto , Autopsia , Cromatografía Líquida de Alta Presión , Diazepam/sangre , Femenino , Vena Femoral , Humanos , Masculino , Persona de Mediana Edad , Espectrometría de Masas en Tándem , Reino Unido
2.
Med Sci Law ; 60(4): 266-269, 2020 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-32838670

RESUMEN

Flubromazolam is a potent triazole benzodiazepine with moderately long-lasting central nervous system-depressant effects relative to other benzodiazepines such as commonly prescribed diazepam. Flubromazolam has been studied in the living. However, there are no published reports including measured drug concentrations in post-mortem cases. We report five cases in which flubromazolam was detected in a systematic screen using high-resolution mass spectrometry and then quantified in femoral blood. In none of the five cases was the cause of death directly attributed to flubromazolam toxicity, as there was a variety of both sedative and stimulant drugs also present. However, it is important that the drug concentrations that were measured are made available for future post-mortem forensic interpretation.


Asunto(s)
Benzodiazepinas/sangre , Toxicología Forense , Adulto , Autopsia , Benzodiazepinas/orina , Drogas de Diseño , Femenino , Humanos , Masculino , Espectrometría de Masas , Persona de Mediana Edad , Detección de Abuso de Sustancias
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA